In English | En español
Questions About Cancer? 1-800-4-CANCER

Find News Releases

Search For:
Between these dates:

All News Releases

UCSF mouse and human studies indicate that cancer prognosis may be related to newly identified immune cell
NCI Cancer Center News
(Posted: 10/17/2014) - A newly discovered population of immune cells in tumors is associated with less severe cancer outcomes in humans, and may have therapeutic potential, according to a new UC San Francisco study of 3,600 human tumors of 12 types, as well as mouse experiments.

Duke researchers find that prostate cancer’s penchant for copper may be a fatal flaw
NCI Cancer Center News
(Posted: 10/15/2014) - Researchers at Duke Medicine have found a way to kill prostate cancer cells by delivering a trove of copper along with a drug that selectively destroys the diseased cells brimming with the mineral, leaving non-cancer cells healthy.

U of Chicago researchers find that SIRT6 prevents some cancers but promotes sun-induced skin cancer
NCI Cancer Center News
(Posted: 10/15/2014) - SIRT6 -- a protein that inhibits the growth of liver and colon cancers -- can promote the development of skin cancers by turning on an enzyme that increases inflammation, proliferation and survival of sun-damaged skin cells.

Stanford researchers find that drug may prevent development of invasive bladder cancer
NCI Cancer Center News
(Posted: 10/14/2014) - A drug that activates targets of the hedgehog signaling pathway, which is lost when bladder cancer invades, could prevent the progression of the disease in humans.

Washington University researchers find that an allergy to metal implants could trigger rare skin cancer
NCI Cancer Center News
(Posted: 10/14/2014) - For some patients, metal implants may increase the risk of an unusual and aggressive form of skin cancer.

Trial results show high remission rate in leukemia following immune cell therapy
NCI News Note
(Posted: 10/12/2014) - Children and young adults (age 1 to age 30) with chemotherapy-resistant B-cell acute lymphoblastic leukemia (ALL) experienced high remission rates following treatment with an experimental immunotherapy. Results demonstrated that the immunotherapy treatment had anti-leukemia effects in patients and that the treatment was feasible and safe.

Thomas Jefferson U researchers find that hormone loss could be involved in colon cancer
NCI Cancer Center News
(Posted: 10/10/2014) - Like diabetes, colon cancer may be caused in part by the loss of one hormone, suggesting hormone replacement therapy could stall cancer formation.

Duke researchers find that elevated cholesterol and triglycerides may increase the risk for prostate cancer recurrence
NCI Cancer Center News
(Posted: 10/10/2014) - Higher levels of total cholesterol and triglycerides, two types of fat, in the blood of men who underwent surgery for prostate cancer, were associated with increased risk for disease recurrence.

Columbia University Medical Center researchers find that a new computational approach finds gene that drives aggressive brain cancer
NCI Cancer Center News
(Posted: 10/10/2014) - Columbia University Medical Center researchers have combined existing computational tools with a new algorithm called DIGGIT, which 'walks' backward from the master regulators to find the genetic events that drive brain cancer.

MD Anderson researchers reveal genomic diversity of individual lung tumors
NCI Cancer Center News
(Posted: 10/10/2014) - Known cancer-driving genomic aberrations in localized lung cancer appear to be so consistently present across tumors that a single biopsy of one region of the tumor is likely to identify most of them, according to a paper published today in Science.

< Previous  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17  Next >